ARMGO Pharma raises $35 million to progress clinical

ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by...

Related Keywords

Germany ,New York ,United States ,Colombia ,Columbia University ,Netherlands ,Singapore ,Dutch ,Ashley Tapp ,Dmitrij Hristodorov ,Geert Jan Mulder ,Iyona Rajkomar ,Peter Neubeck ,Sue Charles ,National Institute Of Health ,European Recovery Programme ,Colombia University ,Pharma Inc ,Dutch Venture Initiative ,Consilium Strategic Communications ,Professor Andrew Marks ,National Institute ,Chief Medical Officer ,Jan Mulder ,Gene Marcantonio ,United Nations Principles ,Kfw Capital ,Venture Capital Fonds ,Armgo ,Armgo Pharma ,Usculoskeletal ,Neurological Disorders ,Financing ,Corbion ,C Investors Pontifax ,Kurma Partners ,